Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Durvalumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Durvalumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Durvalumab Overall Market Size
2.1 Global Durvalumab Market Size: 2021 VS 2028
2.2 Global Durvalumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Durvalumab Sales: 2017-2028
3 Company Landscape
3.1 Top Durvalumab Players in Global Market
3.2 Top Global Durvalumab Companies Ranked by Revenue
3.3 Global Durvalumab Revenue by Companies
3.4 Global Durvalumab Sales by Companies
3.5 Global Durvalumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Durvalumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Durvalumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Durvalumab Players in Global Market
3.8.1 List of Global Tier 1 Durvalumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Durvalumab Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Durvalumab Market Size Markets, 2021 & 2028
4.1.2 2.4mL Injection
4.1.3 10mL Injection
4.2 By Type - Global Durvalumab Revenue & Forecasts
4.2.1 By Type - Global Durvalumab Revenue, 2017-2022
4.2.2 By Type - Global Durvalumab Revenue, 2023-2028
4.2.3 By Type - Global Durvalumab Revenue Market Share, 2017-2028
4.3 By Type - Global Durvalumab Sales & Forecasts
4.3.1 By Type - Global Durvalumab Sales, 2017-2022
4.3.2 By Type - Global Durvalumab Sales, 2023-2028
4.3.3 By Type - Global Durvalumab Sales Market Share, 2017-2028
4.4 By Type - Global Durvalumab Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Durvalumab Market Size, 2021 & 2028
5.1.2 Locally Advanced Urothelial Carcinoma
5.1.3 Metastatic Urothelial Carcinoma
5.1.4 Other
5.2 By Application - Global Durvalumab Revenue & Forecasts
5.2.1 By Application - Global Durvalumab Revenue, 2017-2022
5.2.2 By Application - Global Durvalumab Revenue, 2023-2028
5.2.3 By Application - Global Durvalumab Revenue Market Share, 2017-2028
5.3 By Application - Global Durvalumab Sales & Forecasts
5.3.1 By Application - Global Durvalumab Sales, 2017-2022
5.3.2 By Application - Global Durvalumab Sales, 2023-2028
5.3.3 By Application - Global Durvalumab Sales Market Share, 2017-2028
5.4 By Application - Global Durvalumab Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Durvalumab Market Size, 2021 & 2028
6.2 By Region - Global Durvalumab Revenue & Forecasts
6.2.1 By Region - Global Durvalumab Revenue, 2017-2022
6.2.2 By Region - Global Durvalumab Revenue, 2023-2028
6.2.3 By Region - Global Durvalumab Revenue Market Share, 2017-2028
6.3 By Region - Global Durvalumab Sales & Forecasts
6.3.1 By Region - Global Durvalumab Sales, 2017-2022
6.3.2 By Region - Global Durvalumab Sales, 2023-2028
6.3.3 By Region - Global Durvalumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Durvalumab Revenue, 2017-2028
6.4.2 By Country - North America Durvalumab Sales, 2017-2028
6.4.3 US Durvalumab Market Size, 2017-2028
6.4.4 Canada Durvalumab Market Size, 2017-2028
6.4.5 Mexico Durvalumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Durvalumab Revenue, 2017-2028
6.5.2 By Country - Europe Durvalumab Sales, 2017-2028
6.5.3 Germany Durvalumab Market Size, 2017-2028
6.5.4 France Durvalumab Market Size, 2017-2028
6.5.5 U.K. Durvalumab Market Size, 2017-2028
6.5.6 Italy Durvalumab Market Size, 2017-2028
6.5.7 Russia Durvalumab Market Size, 2017-2028
6.5.8 Nordic Countries Durvalumab Market Size, 2017-2028
6.5.9 Benelux Durvalumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Durvalumab Revenue, 2017-2028
6.6.2 By Region - Asia Durvalumab Sales, 2017-2028
6.6.3 China Durvalumab Market Size, 2017-2028
6.6.4 Japan Durvalumab Market Size, 2017-2028
6.6.5 South Korea Durvalumab Market Size, 2017-2028
6.6.6 Southeast Asia Durvalumab Market Size, 2017-2028
6.6.7 India Durvalumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Durvalumab Revenue, 2017-2028
6.7.2 By Country - South America Durvalumab Sales, 2017-2028
6.7.3 Brazil Durvalumab Market Size, 2017-2028
6.7.4 Argentina Durvalumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Durvalumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Durvalumab Sales, 2017-2028
6.8.3 Turkey Durvalumab Market Size, 2017-2028
6.8.4 Israel Durvalumab Market Size, 2017-2028
6.8.5 Saudi Arabia Durvalumab Market Size, 2017-2028
6.8.6 UAE Durvalumab Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Medimmune (AstraZeneca)
7.1.1 Medimmune (AstraZeneca) Corporate Summary
7.1.2 Medimmune (AstraZeneca) Business Overview
7.1.3 Medimmune (AstraZeneca) Durvalumab Major Product Offerings
7.1.4 Medimmune (AstraZeneca) Durvalumab Sales and Revenue in Global (2017-2022)
7.1.5 Medimmune (AstraZeneca) Key News
8 Global Durvalumab Production Capacity, Analysis
8.1 Global Durvalumab Production Capacity, 2017-2028
8.2 Durvalumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Durvalumab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Durvalumab Supply Chain Analysis
10.1 Durvalumab Industry Value Chain
10.2 Durvalumab Upstream Market
10.3 Durvalumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Durvalumab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer